- Oops!Something went wrong.Please try again later.
Cue Health Inc (NASDAQ: HLTH) will collaborate with Google Cloud to add respiratory viral variant sequencing and tracking to its Cue Integrated Care platform.
Cue said it would build Google Cloud's artificial intelligence, machine learning, analytics, and privacy and security tools into its platform, including its Cue Health Monitoring System and rapid molecular COVID-19 test.
The COVID-19 test delivers results to mobile devices in approximately 20 minutes.
In March, the assay received Emergency Use Authorization from the FDA for home and over-the-counter use.
The integration is also intended to help in future outbreaks of infectious diseases and pandemics beyond COVID-19, including influenza and respiratory syncytial virus.
Cue is currently developing tests for both influenza and RSV, it added.
Recently, Cue Health debuted on NASDAQ.
Price Action: HLTH stock is down 6.75% at $10.08 during the market session on the last check Wednesday.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.